Form 8-K - Current report:
SEC Accession No. 0001437749-20-016059
Filing Date
2020-07-30
Accepted
2020-07-30 18:45:12
Documents
15
Period of Report
2020-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vcyt20200624_8k.htm   iXBRL 8-K 28447
2 EXHIBIT 99.1 ex_191377.htm EX-99.1 210778
7 prlogo.jpg GRAPHIC 6236
  Complete submission text file 0001437749-20-016059.txt   397142

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcyt-20200730.xsd EX-101.SCH 3700
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcyt-20200730_def.xml EX-101.DEF 11586
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcyt-20200730_lab.xml EX-101.LAB 15466
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcyt-20200730_pre.xml EX-101.PRE 11740
8 EXTRACTED XBRL INSTANCE DOCUMENT vcyt20200624_8k_htm.xml XML 2570
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 201061419
SIC: 8071 Services-Medical Laboratories